Affiliation:
1. From the Department of Pharmacology, College of Medicine, The University of Tennessee, Memphis.
Abstract
Abstract
The purpose of this study was to characterize the receptor(s) and second messenger systems involved in prostacyclin (prostaglandin [PG] I
2
) synthesis elicited by endothelin (ET)-1 in the rat aorta. PGI
2
synthesis, measured as immunoreactive 6-keto-PGF
1α
, was assessed in aortic rings exposed to endothelin receptor agonists in the presence and absence of selective ET
A
and ET
B
receptor antagonists. ET-1, which has equal affinity for both endothelin receptor subtypes, and ET-3, a preferential ET
B
receptor agonist, enhanced 6-keto-PGF
1α
synthesis in a time- and concentration-dependent manner. ET-1 was more potent than ET-3 in increasing 6-keto-PGF
1α
synthesis. Moreover, the selective ET
B
receptor agonists IRL-1620 and sarafotoxin S6c did not significantly increase 6-keto-PGF
1α
synthesis. Furthermore, ET-1–induced 6-keto-PGF
1α
synthesis was attenuated by an ET
A
receptor antagonist, BQ-123, in a dose-dependent manner but not by an ET
B
receptor antagonist, BQ-788. Depletion of extracellular Ca
2+
or addition of Ca
2+
channel blockers (nifedipine, verapamil, SK&F 96365) attenuated ET-1–mediated 6-keto-PGF
1α
synthesis, while a Ca
2+
channel agonist,
S
(−)-Bay K 8644, potentiated this effect of ET-1. Selective protein kinase C inhibitors (bisindolylmaleimide I, calphostin C) did not alter ET-1–induced 6-keto-PGF
1α
synthesis. These data suggest that PGI
2
synthesis elicited by ET-1 in the rat aorta is mediated primarily through influx of extracellular Ca
2+
via activation of an ET
A
receptor and is independent of protein kinase C.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献